TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair